GlassScriptPhysician profile
Maxine Theriot
NPI 1194874628
$757.84
in general payments reported to CMS, 2019-2025
12 companies · $60.82 in 2025
The $60.82 reported for 2025 was less than what a typical Undersea and Hyperbaric Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $210).
See the full distribution for Undersea and Hyperbaric Medicine (Preventive Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $65.13 · 2021: $89.66 · 2022: $63.17 · 2023: $149 · 2024: $137 · 2025: $60.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $373.34 | 2019-2024 | Collagenase Santyl, Renasys Go V2 Home, Pico 7 |
| Misonix INC | $87.76 | 2020-2021 | |
| Convatec INC. | $76.12 | 2024-2025 | |
| Kerecis Limited | $46.02 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $43.55 | 2023 | Puraply |
| Sage Therapeutics, LLC | $35.61 | 2022 | |
| Kci USA, INC. | $22.30 | 2023 | Activ.A.C., Promogran Prisma, Kerramax Care |
| Aroa Biosurgery Incorporated | $16.60 | 2020 | |
| Integra Lifesciences Corporation | $15.61 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.26 | 2023 | Nuzyra |
| Abbvie INC. | $13.40 | 2023 | Dalvance |
| Tactile Systems Technology INC | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxine Theriot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.